Latest News

Reston, VA—Peptide receptor radionuclide therapy (PRRT) is effective for clinical control of symptomatic metastatic insulinomas, according to new research published in the February issue of The Journal of Nuclear Medicine. In the largest study to date of metastatic insulinoma patients treated with PRRT, more than 80 percent of patients had long-lasting...
Birmingham, UK – Patients with lung disease are more likely to develop heart disease independent of any risk factors, according to new research. A new study published in Orphanet Journal of Rare Diseases looked at patients who have a rare genetic condition called Alpha-1 antitrypsin deficiency (AATD) which causes lung...
BUFFALO, NY – A new research paper was published in Aging  Volume 16, Issue 3, entitled, “Defining the progeria phenome.” Progeroid disorders are a heterogenous group of rare and complex hereditary syndromes presenting with pleiotropic phenotypes associated with normal aging. Due to the large variation in clinical presentation the diseases...
Copenhagen, Denmark – A substance naturally occurring in i.a. pomegranates, strawberries and walnuts can improve memory and treatment of Alzheimer’s disease, a new study conducted at the University of Copenhagen concludes. Forgetfulness, difficulty finding words and confusion about time and place. These are some of the most common symptoms of...
Exeter, England – Physical activity in natural environments prevent almost 13,000 cases of non-communicable diseases a year in England and save treatment costs of more than £100m, new research from the University of Exeter has found. According to the World Health Organization (WHO) the most common non-communicable diseases – including...
Liverpool, UK – A significant breakthrough in breast cancer research has uncovered a key mechanism driving cancer invasion and drug resistance. A University of Liverpool study reveals how two critical molecules present in ‘HER2-positive’ breast cancer – one of the most aggressive forms – influence breast cancer survival and its...